These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37192858)

  • 21. [Knockdown the expression of ku70 and lig4 in HEK293T cells by CRISPR/Cas13 system].
    Wang H; Li G; Huang G; Li Z; Zheng E; Xu Z; Yang H; Wu Z; Zhang X; Liu D
    Sheng Wu Gong Cheng Xue Bao; 2020 Jul; 36(7):1414-1421. PubMed ID: 32748599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Use of CRISPR/Cas13 Machinery in Understanding Virus-Host Interaction.
    Bayoumi M; Munir M
    Front Microbiol; 2021; 12():743580. PubMed ID: 34899631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programmable Inhibition and Detection of RNA Viruses Using Cas13.
    Freije CA; Myhrvold C; Boehm CK; Lin AE; Welch NL; Carter A; Metsky HC; Luo CY; Abudayyeh OO; Gootenberg JS; Yozwiak NL; Zhang F; Sabeti PC
    Mol Cell; 2019 Dec; 76(5):826-837.e11. PubMed ID: 31607545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CaSilico: A versatile CRISPR package for
    Asadbeigi A; Norouzi M; Vafaei Sadi MS; Saffari M; Bakhtiarizadeh MR
    Front Bioeng Biotechnol; 2022; 10():957131. PubMed ID: 36017348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live imaging of RNA and RNA splicing in mammalian cells via the dcas13a-SunTag-BiFC system.
    Chen M; Sui T; Yang L; Qian Y; Liu Z; Liu Y; Wang G; Lai L; Li Z
    Biosens Bioelectron; 2022 May; 204():114074. PubMed ID: 35149451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted inhibition of Zika virus infection in human cells by CRISPR-Cas13b.
    Chen P; Chen M; Chen Y; Jing X; Zhang N; Zhou X; Li X; Long G; Hao P
    Virus Res; 2022 Apr; 312():198707. PubMed ID: 35150770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
    Charpentier E; Richter H; van der Oost J; White MF
    FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
    Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
    RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice.
    Keng CT; Yogarajah T; Lee RCH; Muhammad IBH; Chia BS; Vasandani SR; Lim DS; Guo K; Wong YH; Mok CK; Chu JJH; Chew WL
    EBioMedicine; 2023 Jul; 93():104682. PubMed ID: 37390772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
    Kavuri NR; Ramasamy M; Qi Y; Mandadi K
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inert Pepper aptamer-mediated endogenous mRNA recognition and imaging in living cells.
    Wang Q; Xiao F; Su H; Liu H; Xu J; Tang H; Qin S; Fang Z; Lu Z; Wu J; Weng X; Zhou X
    Nucleic Acids Res; 2022 Aug; 50(14):e84. PubMed ID: 35580055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA editing with CRISPR-Cas13.
    Cox DBT; Gootenberg JS; Abudayyeh OO; Franklin B; Kellner MJ; Joung J; Zhang F
    Science; 2017 Nov; 358(6366):1019-1027. PubMed ID: 29070703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification.
    Quansah E; Chen Y; Yang S; Wang J; Sun D; Zhao Y; Chen M; Yu L; Zhang C
    Front Microbiol; 2023; 14():1076947. PubMed ID: 36760507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
    Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
    Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
    Li PY; Li SQ; Gao SG; Dong DY
    Med Hypotheses; 2022 Feb; 159():110754. PubMed ID: 35002020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Generations of MS2 Variants and MCP Fusions to Detect Single mRNAs in Living Eukaryotic Cells.
    Pichon X; Robert MC; Bertrand E; Singer RH; Tutucci E
    Methods Mol Biol; 2020; 2166():121-144. PubMed ID: 32710406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced RNA knockdown efficiency with engineered fusion guide RNAs that function with both CRISPR-CasRx and hammerhead ribozyme.
    Zhan Y; Cao C; Li A; Mei H; Liu Y
    Genome Biol; 2023 Jan; 24(1):9. PubMed ID: 36650600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
    Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
    Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.